12 results on '"Gordon T. Luu"'
Search Results
2. Metabolomics of bacterial-fungal pairwise interactions reveal conserved molecular mechanisms
- Author
-
Gordon T. Luu, Jessica C. Little, Emily C. Pierce, Manon Morin, Celine A. Ertekin, Benjamin E. Wolfe, Oliver Baars, Rachel J. Dutton, and Laura M. Sanchez
- Subjects
Article - Abstract
Bacterial-fungal interactions (BFIs) can shape the structure of microbial communities, but the small molecules mediating these BFIs are often understudied. We explored various optimization steps for our microbial culture and chemical extraction protocols for bacterial-fungal co-cultures, and liquid chromatography-tandem mass spectrometry (LC-MS/MS) revealed that metabolomic profiles are mainly comprised of fungi derived features, indicating that fungi are the key contributors to small molecule mediated BFIs. LC-inductively coupled plasma MS (LC-ICP-MS) and MS/MS based dereplication using database searching revealed the presence of several known fungal specialized metabolites and structurally related analogues in these extracts, including siderophores such as desferrichrome, desferricoprogen, and palmitoylcoprogen. Among these analogues, a novel putative coprogen analogue possessing a terminal carboxylic acid motif was identified fromScopulariopsisspp. JB370, a common cheese rind fungus, and its structure was elucidated via MS/MS fragmentation. Based on these findings, filamentous fungal species appear to be capable of producing multiple siderophores with potentially different biological roles (i.e. various affinities for different forms of iron). These findings highlight that fungal species are important contributors to microbiomes via their production of abundant specialized metabolites and their role in complex communities should continue to be a priority.
- Published
- 2023
3. A Universal Language for Finding Mass Spectrometry Data Patterns
- Author
-
Alan K. Jarmusch, Allegra T. Aron, Daniel Petras, Vanessa V. Phelan, Wout Bittremieux, Deepa D. Acharya, Mohammed M. A. Ahmed, Anelize Bauermeister, Matthew J. Bertin, Paul D. Boudreau, Ricardo M. Borges, Benjamin P. Bowen, Christopher J. Brown, Fernanda O. Chagas, Kenneth D. Clevenger, Mario S. P. Correia, William J. Crandall, Max Crüsemann, Tito Damiani, Oliver Fiehn, Neha Garg, William H Gerwick, Jeffrey R. Gilbert, Daniel Globisch, Paulo Wender P. Gomes, Steffen Heuckeroth, C. Andrew James, Scott A. Jarmusch, Sarvar A. Kakhkhorov, Kyo Bin Kang, Roland D Kersten, Hyunwoo Kim, Riley D. Kirk, Oliver Kohlbacher, Eftychia E. Kontou, Ken Liu, Itzel Lizama-Chamu, Gordon T. Luu, Tal Luzzatto Knaan, Michael T. Marty, Andrew C. McAvoy, Laura-Isobel McCall, Osama G. Mohamed, Omri Nahor, Timo H.J. Niedermeyer, Trent R. Northen, Kirsten E. Overdahl, Tomáš Pluskal, Johannes Rainer, Raphael Reher, Elys Rodriguez, Timo T. Sachsenberg, Laura M. Sanchez, Robin Schmid, Cole Stevens, Zhenyu Tian, Ashootosh Tripathi, Hiroshi Tsugawa, Kozo Nishida, Yuki Matsuzawa, Justin J.J. van der Hooft, Andrea Vicini, Axel Walter, Tilmann Weber, Quanbo Xiong, Tao Xu, Haoqi Nina Zhao, Pieter C. Dorrestein, and Mingxun Wang
- Abstract
Even though raw mass spectrometry data is information rich, the vast majority of the data is underutilized. The ability to interrogate these rich datasets is handicapped by the limited capability and flexibility of existing software. We introduce the Mass Spec Query Language (MassQL) that addresses these issues by enabling an expressive set of mass spectrometry patterns to be queried directly from raw data. MassQL is an open-source mass spectrometry query language for flexible and mass spectrometer manufacturer-independent mining of MS data. We envision the flexibility, scalability, and ease of use of MassQL will empower the mass spectrometry community to take fuller advantage of their mass spectrometry data and accelerate discoveries.
- Published
- 2022
- Full Text
- View/download PDF
4. Evaluation of Data Analysis Platforms and Compatibility with MALDI-TOF Imaging Mass Spectrometry Data Sets
- Author
-
Lars E. P. Dietrich, Lisa Juliane Kahl, Gordon T. Luu, Alanna R. Condren, and Laura M. Sanchez
- Subjects
MALDI-TOF ,Analyte ,data analysis ,Bioengineering ,010402 general chemistry ,computer.software_genre ,imaging mass spectrometry ,01 natural sciences ,Article ,Mass spectrometry imaging ,Analytical Chemistry ,Medicinal and Biomolecular Chemistry ,Software ,Structural Biology ,Preprocessor ,Spatial analysis ,Cardinal ,Spectroscopy ,Data processing ,Chemistry ,business.industry ,010401 analytical chemistry ,SCiLS ,0104 chemical sciences ,Data set ,Networking and Information Technology R&D (NITRD) ,DECIPHER ,Data mining ,business ,computer ,data processing ,Physical Chemistry (incl. Structural) - Abstract
Imaging mass spectrometry (IMS) has proven to be a useful tool when investigating the spatial distributions of metabolites and proteins in a biological system. One of the biggest advantages of IMS is the ability to maintain the 3D chemical composition of a sample and analyze it in a label-free manner. However, acquiring the spatial information leads to an increase in data size. Due to the increased availability of commercial mass spectrometers capable of IMS, there has been an exciting development of different statistical tools that can help decipher the spatial relevance of an analyte in a biological sample. To address this need, software packages like SCiLS and the open source R package Cardinal have been designed to perform unbiased spectral grouping based on the similarity of spectra in an IMS data set. In this note, we evaluate SCiLS and Cardinal compatibility with MALDI-TOF IMS data sets of the Gram-negative pathogen Pseudomonas aeruginosa PA14. Both software were able to perform unsupervised segmentation with similar performance. There were a few notable differences which are discussed related to the identification of statistically significant features which required optimization of preprocessing steps, region of interest, and manual analysis.
- Published
- 2020
- Full Text
- View/download PDF
5. An integrated approach to protein discovery and detection from complex biofluids
- Author
-
Gordon T. Luu, Chang Ge, Yisha Tang, Kailiang Li, Stephanie M. Cologna, Joanna E. Burdette, Judith Su, and Laura M. Sanchez
- Abstract
Ovarian cancer, a leading cause of cancer related deaths among women, has been notoriously difficult to routinely screen for and diagnose early. Researchers and clinicians continue to seek routinely usable, non-invasive, screening methods as early detection significantly improves survival. Biomarker screening is ideal; however, currently available ovarian cancer biomarkers lack desirable sensitivity and specificity. Furthermore, the most fatal forms, high grade serous cancers often originate in the fallopian tube; therefore, sampling from the vaginal environment provides more proximal sources for tumor detection. To address these shortcomings and leverage proximal sampling, we developed an untargeted mass spectrometry microprotein profiling method and identified a signature of cystatin A, validated this protein in an animal model, and sought to overcome the limits of detection inherent to mass spectrometry by demonstrating that cystatin A is present at 100 pM concentrations using a label-free microtoroid resonator. The findings highlight the potential utility for early-stage detection where cystatin A levels would be low.Significance StatementIt is now clear that high-grade serous ovarian cancer can originate in the fallopian tube epithelium. These tumors colonize the ovary and then metastasize throughout the peritoneum. This discovery has raised important, and yet unaddressed, questions how we might be able to detect and screen for this deadly disease for which there is no routine screening. We have leveraged vaginal lavages from a murine model of the disease as a complex biological fluid for untargeted discovery of microproteins using mass. We improved our limits of detection by conjugating a cystatin A antibody to the surface of a microtoroid resonator to allow us to specifically detect cystatin A from vaginal lavages at early time points across biological replicates.
- Published
- 2022
- Full Text
- View/download PDF
6. TIMSCONVERT: A workflow to convert trapped ion mobility data to open data formats
- Author
-
Gordon T. Luu, Itzel Lizama-Chamu, Catherine S. McCaughey, Laura M. Sanchez, and Mingxun Wang
- Abstract
SummaryAdvances in mass spectrometry instrumentation have led to the development of mass spectrometers with ion mobility separation (IMS) capabilities and dual source instrumentation, but the current software ecosystem lacks interoperability with downstream data analysis using open-source software/pipelines. Here, we present TIMSCONVERT, a data conversion workflow from timsTOF fleX MS raw data files to size conscious mzML and imzML formats with minimal preprocessing to allow for compatibility with downstream data analysis tools, which we showcase with several examples using data acquired across different experiments and acquisition modalities on the timsTOF fleX.Availability and ImplementationTIMSCONVERT and its documentation can be found at https://github.com/gtluu/timsconvert and is available as a standalone command line interface, Nextflow workflow, and online in the Global Natural Products Social (GNPS) platform (https://proteomics2.ucsd.edu/ProteoSAFe/index.jsp?params={%22workflow%22%3A%20%22TIMSCONVERT%22}).ContactMingxun Wang, miw023@ucsd.eduSupplementary InformationSupplementary data are available at Bioinformatics online.
- Published
- 2021
- Full Text
- View/download PDF
7. Toward improvement of screening through mass spectrometry-based proteomics: ovarian cancer as a case study
- Author
-
Laura M. Sanchez and Gordon T Luu
- Subjects
Context (language use) ,Computational biology ,Proteomics ,Article ,Analytical Chemistry ,Causes of cancer ,ofiling ,Rare Diseases ,medicine ,MALDI-TOF MS ,Physical and Theoretical Chemistry ,Biomarker discovery ,Fingerprinting ,Instrumentation ,Spectroscopy ,Cancer ,screening and diagnosis ,Mass spectrometry based proteomics ,Chemistry ,Prevention ,Organic Chemistry ,Condensed Matter Physics ,medicine.disease ,Ovarian Cancer ,4.1 Discovery and preclinical testing of markers and technologies ,Detection ,Screening ,Biomarker (medicine) ,Protein identification ,4.4 Population screening ,Ovarian cancer ,Biomarkers ,Physical Chemistry (incl. Structural) - Abstract
Ovarian cancer is one of the leading causes of cancer related deaths affecting United States women. Early-stage detection of ovarian cancer has been linked to increased survival, however, current screening methods, such as biomarker testing, have proven to be ineffective in doing so. Therefore, further developments are necessary to be able to achieve positive patient prognosis. Ongoing efforts are being made in biomarker discovery towards clinical applications in screening for early-stage ovarian cancer. In this perspective, we discuss and provide examples for several workflows employing mass spectrometry-based proteomics towards protein biomarker discovery and characterization in the context of ovarian cancer; workflows include protein identification and characterization as well as intact protein profiling. We also discuss the opportunities to merge these workflows for a multiplexed approach for biomarkers. Lastly, we provide our insight as to future developments that may serve to enhance biomarker discovery workflows while also considering translational potential.
- Published
- 2021
8. Correction to: CpG‑creating mutations are costly in many human viruses
- Author
-
Samuel Melvin Goodfellow, Shannel Bermudez, Nicole Allen, Kaho H. Tisthammer, Anjani Pradhananga, Caroline Solis, Katia Koelle, Jasmeen Kaur, Jacky Lo, Kellen Hopp, Krystal Tran, Emily Fryer, Christen Kinney, Alejandro G. Lopez, Katrina A. Lythgoe, Albert Wong, Elizabeth J. Winters, Livia Tran, Hasan Sulaeman, Pleuni S. Pennings, Milo Aviles, Adrienne Le, E. Geo Pineda, Rebecca L. Melton, William Bauer, Corey Carlson, Derek Lao, Amirhossein Jaberi, Jacob Elliot, Gordon T. Luu, Rima Singh, Andrew R. Mahoney, Roland R. Regoes, Victoria R. Caudill, Natalie Fiutek, Scott William Roy, Fernando G. Lorenzo, Jennifer Kim, Ricky Thu, Rosalind M Eggo, Mordecai Hecht, E. Deshawn Hopson, Ryan Winstead, Angeline Katia Chemel, Trevor Bedford, Dwayne Evans, Jasmine Sims, Sarina Qin, Gabriela Do Nascimento, Nicole S. Rodrigues, Oana Carja, Annie Shieh, Andrea López, Brittany A. Baker, Francisca L. Catalan, Sarah Cobey, and Edgar Castellanos
- Subjects
CpG site ,Animal ecology ,Evolutionary biology ,Ecology (disciplines) ,Biology ,Publication process ,Ecology, Evolution, Behavior and Systematics - Abstract
In the original article, the co-author name "Jennifer Kim" has been inadvertently missed during the publication process. The complete author group is given in this correction.
- Published
- 2020
- Full Text
- View/download PDF
9. Imaging mass spectrometry for natural products discovery: a review of ionization methods
- Author
-
Laura M. Sanchez, Gordon T. Luu, and Joseph E. Spraker
- Subjects
0301 basic medicine ,Secondary Ion ,Spectrometry, Mass, Electrospray Ionization ,Computer science ,Spectrometry, Mass, Secondary Ion ,Microscopy, Atomic Force ,01 natural sciences ,Biochemistry ,Medical and Health Sciences ,Multimodal Imaging ,Mass spectrometry imaging ,Fluorescence ,Mass Spectrometry ,Article ,Mini review ,Workflow ,03 medical and health sciences ,Laser therapy ,Drug Discovery ,Matrix-Assisted Laser Desorption-Ionization ,Multimodal imaging ,Microscopy ,Biological Products ,Extramural ,Spectrometry ,010401 analytical chemistry ,Electrospray Ionization ,Organic Chemistry ,Spatial mapping ,Atomic Force ,Mass ,Biological Sciences ,0104 chemical sciences ,030104 developmental biology ,Microscopy, Fluorescence ,Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization ,Chemical Sciences ,Biochemical engineering ,Laser Therapy - Abstract
Covering: 2009-2019 Over the last decade, methods in imaging mass spectrometry (IMS) have progressively improved and diversified toward a variety of applications in natural products research. Because IMS allows for the spatial mapping of the production and distribution of biologically active molecules in situ, it facilitates phenotype and organelle driven discovery efforts. As practitioners of IMS for natural products discovery, we find one of the most important aspects of these experiments is the sample preparation and compatibility with different ionization sources that are available to a given researcher. As such, we have focused this mini review to cover types of ionization sources that have been used in natural products discovery applications and provided concrete examples of use for natural products discovery while discussing the advantages and limitations of each method. We aim for this article to serve as a resource to guide the broader natural product community interested in IMS toward the application/method that would best serve their natural product discovery needs given the sample and analyte(s) of interest. This mini review has been limited to applications using natural products and thus is not exhaustive of all possible ionization methods which have only been applied to image other types of samples such as mammalian tissues. Additionally, we briefly review how IMS has been coupled with other imaging platforms, such as microscopy, to enhance information outputs as well as offer our future perspectives on the incorporation of IMS in natural products discovery.
- Published
- 2019
10. CpG-creating Mutations are Costly in Many Human Viruses
- Author
-
Corey Carlson, Samuel Melvin Goodfellow, Nicole Allen, Pleuni S. Pennings, Milo Aviles, Jacky Lo, Rima Singh, Andrew R. Mahoney, Shannel Bermudez, Rebecca L. Melton, Anjani Pradhananga, Annie Shieh, Mordecai Hecht, Sarah Cobey, William Bauer, Francisca L. Catalan, Kellen Hopp, Edgar Castellanos, Ryan Winstead, Hasan Sulaeman, Angeline Katia Chemel, Rosalind M Eggo, Alejandro G. Lopez, Ricky Thu, Adrienne Le, Victoria R. Caudill, Trevor Bedford, E. Geo Pineda, Livia Tran, Andrea López, Fernando G. Lorenzo, Dwayne Evans, Sarina Qin, Gabriela Do Nascimento, Amirhossein Jaberi, Nicole S. Rodrigues, Oana Carja, Katia Koelle, Brittany A. Baker, Gordon T. Luu, Elizabeth J. Winters, Krystal Tran, Christen Kinney, Natalie Fiutek, Scott William Roy, Roland R. Regoes, Katrina A. Lythgoe, Caroline Solis, Jasmeen Kaur, Emily Fryer, Albert Wong, Kaho H. Tisthammer, Derek Lao, Jacob Elliot, E. Deshawn Hopson, and Jasmine Sims
- Subjects
0106 biological sciences ,0301 basic medicine ,viruses ,CpG sites ,Mutations ,Viruses ,Fitness costs ,Biology ,medicine.disease_cause ,010603 evolutionary biology ,01 natural sciences ,Genome ,Virus ,03 medical and health sciences ,0302 clinical medicine ,medicine ,Gene ,Allele frequency ,Ecology, Evolution, Behavior and Systematics ,030304 developmental biology ,Genetics ,0303 health sciences ,Mutation ,Original Paper ,Transition (genetics) ,3. Good health ,030104 developmental biology ,CpG site ,Animal ecology ,GenBank ,030217 neurology & neurosurgery - Abstract
Mutations can occur throughout the virus genome and may be beneficial, neutral or deleterious. We are interested in mutations that yield a C next to a G, producing CpG sites. CpG sites are rare in eukaryotic and viral genomes. For the eukaryotes, it is thought that CpG sites are rare because they are prone to mutation when methylated. In viruses, we know less about why CpG sites are rare. A previous study in HIV suggested that CpG-creating transition mutations are more costly than similar non-CpG-creating mutations. To determine if this is the case in other viruses, we analyzed the allele frequencies of CpG-creating and non-CpG-creating mutations across various strains, subtypes, and genes of viruses using existing data obtained from Genbank, HIV Databases, and Virus Pathogen Resource. Our results suggest that CpG sites are indeed costly for most viruses. By understanding the cost of CpG sites, we can obtain further insights into the evolution and adaptation of viruses., Evolutionary Ecology, 34, ISSN:0269-7653, ISSN:1573-8477
- Published
- 2019
- Full Text
- View/download PDF
11. Staring into the void: demystifying microbial metabolomics
- Author
-
Laura M. Sanchez, Gordon T. Luu, and Cynthia M Grim
- Subjects
0303 health sciences ,Primary (chemistry) ,Agricultural and Veterinary Sciences ,010401 analytical chemistry ,microbiology ,Computational biology ,Biological Sciences ,01 natural sciences ,Medical and Health Sciences ,Microbiology ,Mass Spectrometry ,0104 chemical sciences ,03 medical and health sciences ,Metabolomics ,Biological significance ,Health informatics tools ,Genetics ,Metabolome ,Minireview ,Molecular Biology ,030304 developmental biology - Abstract
Metabolites give us a window into the chemistry of microbes and are split into two subclasses: primary and secondary. Primary metabolites are required for life whereas secondary metabolites have historically been classified as those appearing after exponential growth and are not necessarily needed for survival. Many microbial species are estimated to produce hundreds of metabolites and can be affected by differing nutrients. Using various analytical techniques, metabolites can be directly detected in order to elucidate their biological significance. Currently, a single experiment can produce anywhere from megabytes to terabytes of data. This big data has motivated scientists to develop informatics tools to help target specific metabolites or sets of metabolites. Broadly, it is imperative to identify clear biological questions before embarking on a study of metabolites (metabolomics). For instance, studying the effect of a transposon insertion on phenazine biosynthesis in Pseudomonas is a very different from asking what molecules are present in a specific banana-derived strain of Pseudomonas. This review is meant to serve as a primer for a ‘choose your own adventure’ approach for microbiologists with limited mass spectrometry expertise, with a strong focus on liquid chromatography mass spectrometry based workflows developed or optimized within the past five years.
- Published
- 2019
12. BLANKA: an algorithm for blank subtraction in mass spectrometry of complex biological samples
- Author
-
Jessica L. Cleary, Gordon T. Luu, Laura M. Sanchez, Rachel J. Dutton, and Emily C Pierce
- Subjects
Computational biology ,010402 general chemistry ,Mass spectrometry ,Proteomics ,01 natural sciences ,Plant life ,Article ,Analytical Chemistry ,Workflow ,Medicinal and Biomolecular Chemistry ,Metabolomics ,Structural Biology ,Tandem Mass Spectrometry ,Statistical analyses ,Matrix-Assisted Laser Desorption-Ionization ,Microbiome ,LC-MS/MS ,Spectroscopy ,Chromatography ,Liquid ,Multispecies interactions ,Background subtraction ,Bacteria ,Spectrometry ,Chemistry ,Cheese curd media ,010401 analytical chemistry ,Fungi ,MS ,Mass ,LC-MS ,0104 chemical sciences ,Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization ,Function (biology) ,Algorithms ,Software ,Physical Chemistry (incl. Structural) ,Chromatography, Liquid - Abstract
Multispecies microbiome systems are known to be closely linked to human, animal, and plant life processes. The growing field of metabolomics presents the opportunity to detect changes in overall metabolomic profiles of microbial species interactions. These metabolomic changes provide insight into function of metabolites as they correlate to different species presence and the observed phenotypic changes, but detection of subtle changes is often difficult in samples with complex backgrounds. Natural environments such as soil and food contain many molecules that convolute mass spectrometry-based analyses, and identification of microbial metabolites amongst environmental metabolites is an informatics problem we begin to address here. Our microbes are grown on solid or liquid cheese curd media. This medium, which is necessary for microbial growth, contains high amounts of salts, lipids, and casein breakdown products which make statistical analyses using LC-MS/MS data difficult due to the high background from the media. We have developed a simple algorithm to carry out background subtraction from microbes grown on solid or liquid cheese curd media to aid in our ability to conduct statistical analyses so that we may prioritize metabolites for further structure elucidation. Graphical Abstract .
- Published
- 2019
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.